In comparison to the upstream antagonists, downstream inhibition of HH-GLI signaling demonstrated by experimental GLI antagonist, GANT-61, has shown to be most efficient in attenuating melanoma cell viability [10]. This evidence concerns the gene GLI1 and melanoma.